Gendx Tissue Typing Tender, USA - 123649292

Procurement Summary

Country: USA

Summary: Gendx Tissue Typing

Deadline: 06 Aug 2025

Other Information

Notice Type: Tender

TOT Ref.No.: 123649292

Document Ref. No.: 36C26325Q1006

Financier: Self Financed

Purchaser Ownership: Public

Tender Value: Refer Document

Purchaser's Detail

Name: Login to see tender_details

Address: Login to see tender_details

Email: Login to see tender_details

Login to see details

Tender Details

Description

This is a Notice of Intent published in accordance with Federal Acquisition Regulation (FAR) 5.101(a)(1) requiring the dissemination of information regarding proposed contract actions. This Notice of Intent is for a proposed award of a sole source firm fixed price contract to the following contractor in support of needed Next Generation Sequencing (NGS) kits to support the Iowa City VA Health Care System.



GENDx PRODUCTS LLC

SAM UEI: JFZKARM2NL52

15222 Avenue Of Science STE A

San Diego, California

92128-3422, United States



This is done under authority of 41 U.S.C. 3304(a)(1), as implemented by FAR 6.302-1: Only one source and no other supplies or services will satisfy agency requirements.



This is not a request for competitive quotes.



Market research revealed that GENDx PRODUCTS LLC is the sole company that is able to provide support for the needed Next Generation Sequencing (NGS) kits to support the Iowa City VA Health Care System.



The North American Industry Classification System (NAICS) code for this service is 325413 (In Vitro Diagnostic Substance Manufacturing) and the Product Service Code (PSC) is 6550 (In Vitro Diagnostic Substances, Reagents, Test Kits and Sets).



While this synopsis does not constitute a solicitation, interested vendors may identify their interest and capability to satisfy the requirement, including documentation from the proprietary rights holder GENDx PRODUCTS LLC that such contractor could provide this service as an authorized reseller, authorized dealer or third party.



All responsible sources may submit a capability statement, which shall be considered by the agency by e-mailing such statement and supporting documentation to Emanuel Nevarez, Contracting Specialist emanuel.nevarez@va.gov. No phone calls please. Please indicate “36C26325Q1006 BD GENDx Tissue Typing” in subject line of e-mail.





Such documentation will be reviewed solely...
Active Contract Opportunity
Notice ID : 36C26325Q1006
Related Notice
Department/Ind. Agency : VETERANS AFFAIRS, DEPARTMENT OF
Sub-tier : VETERANS AFFAIRS, DEPARTMENT OF
Office: NETWORK CONTRACT OFFICE 23 (36C263)
General Information
Contract Opportunity Type: Special Notice (Original)
Original Published Date: Jul 30, 2025 10:11 pm CDT
Original Response Date: Aug 06, 2025 01:00 pm CDT
Inactive Policy: 15 days after response date
Original Inactive Date: Aug 21, 2025
Initiative: None

Classification
Original Set Aside: No Set aside used
Product Service Code: 6550 - IN VITRO DIAGNOSTIC SUBSTANCES, REAGENTS, TEST KITS AND SETS
NAICS Code: 325413 - In-Vitro Diagnostic Substance Manufacturing

Place of Performance: Iowa City, IA 52246 USA

Documents

 Tender Notice

GenDx-Reagents-SOW-FY26.docx